Manoj Kumar

In silico structure-based design of a novel class of potent and selective small peptide inhibitor of Mycobacterium tuberculosis Dihydrofolate reductase, a potential target for anti-TB drug discovery

Manoj Kumar, Rajakrishnan Vijayakrishnan, Gita Subba Rao · Molecular Diversity · 2009 · 39 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Structural modeling of Omicron spike protein and its complex with human ACE-2 receptor: Molecular basis for high transmissibility of the virus

Tirthankar Koley, Manoj Kumar, Arunima Goswami et al. · Biochemical and Biophysical Research Communications · 2022 · 33 citations · Full text

Life Sciences, Biology, Molecular Biology +17

Structure‐Based Design of a Novel Class of Potent Inhibitors of InhA, the Enoyl Acyl Carrier Protein Reductase from <i>Mycobacterium Tuberculosis</i>: A Computer Modelling Approach

Gita Subba Rao, Rajakrishnan Vijayakrishnan, Manoj Kumar · Chemical Biology & Drug Design · 2008 · 27 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Association of <i>HLA-G</i> 3’UTR Polymorphisms with Soluble HLA-G Levels and Disease Activity in Patients with Rheumatoid Arthritis: A Case-Control Study

Surabhi Gautam, Uma Kumar, Manoj Kumar et al. · Immunological Investigations · 2019 · 27 citations

Life Sciences, Genetics, Immunology +17

Structural analysis of COVID-19 spike protein in recognizing the ACE2 receptor of different mammalian species and its susceptibility to viral infection

Tirthankar Koley, Shivani Madaan, Sanghati Roy Chowdhury et al. · 3 Biotech · 2021 · 24 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17